Skip to content

Image guided Pre-operative Accelerated partial Breast Irradiation (PAPBI): Defening radiotherapy sensivity.

Image guided Pre-operative Accelerated partial Breast Irradiation (PAPBI): Defening radiotherapy sensivity.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25288
Enrollment
120
Registered
2010-11-30
Start date
2009-01-15
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer, partial breast radiotherapy, pre-operative borstkanker, partiele borst bestraling, pre-operatief

Interventions

The additional procedures in this study are: 1. Biopsies before radiotherapy
2. Cytology at day 2 and 12 of radiotherapy
3. MRI before operation
4. A Pet scan will be done twice
5. Also, the sentinel procedure will take place before radiotherapy.

Sponsors

NKI-AVL Plesmanlaan 121 1066 CX Amsterdam Amsterdam, the Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients ≥ 60 years of age with proven adenocarcinoma of the breast presenting with an unifocal lesion on mammogram and MRI (no diffuse microcalcifications), tumor size up till 3.0 cm.

Exclusion criteria

Exclusion criteria: 1. Age < 60 year; 2. Multifocal disease; 3. Lobulair carcinoom; 4. pN+.

Design outcomes

Primary

MeasureTime frame
Tumor response after radiotherapy will histologically be evaluated. Local control will be evaluated during follow-up. Cosmetic evaluation will take place including digital photographs which will be analyze using computer software as well as questionnaires for the patient and treating physician.

Secondary

MeasureTime frame
mRNA gene expression profiles, miRNA expression profiles and DNA copy number changes associated with response to radiotherapy defined as pathologic response assessed in the lumpectomy 6 weeks after radiotherapy will be identified. 60 Patients will be studied as a test set to identify predictive profiles. Responders are defined as Complete Respons and >50% Partial Response 6 weeks after radiotherapy. It is estimated, based on literature, that 50% of the patients will be defined responders. 60 Patients will be studied as a test set to identify predictive profiles; 60 patients will be used as a validation set.

Contacts

Public ContactPaula Elkhuizen

Plesmanlaan 121

p.elkhuizen@nki.nl+31 (0)20 5122120

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)